Prejunctional effects of angiotensin II and bradykinin in the heart and blood vessels

Journal of Autonomic Pharmacology

Volumn 19, Issue 6, 1999, Pages 321-325

  Moura, D ^a   Pinheiro, H ^a   Paiva, M Q ^a   Guimaraes S ^a  

^a Institute of Pharmacology and Therapeutics   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ; ICATIBANT; LOSARTAN; NORADRENALIN; RAMIPRILAT; RECEPTOR SUBTYPE; SARALASIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCARDIUM; HEART ATRIUM; HEART VENTRICLE; INOTROPISM; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; RAT; SYMPATHETIC NERVE;

EID: 0033306179     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2680.1999.tb00004.x     Document Type: Article

References (37)

1. ADMIRAAL, P.J.J., DERKX, F.H.M., DANSER, A.H.J., PIETERMAN, H. & SCHALEKAMP, M.A.D.H. (1990). Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension, 15, 44-55.
2. BAYDOUN, A.R., PEERS, S.H., CIRINO, G. & WOODWARD, B. (1989). Effects of endothelin 1 on the rat isolated heart. J. Cardiovasc. Pharmacol., 13(Suppl. 5), S193-S196.
3. BRUTSAERT, D.L. & ANDRIES, L.J. (1992). The endocardial endothelium. Am. J. Physiol., 263, H985-H1002.
4. BRUTSAERT, D.L., MEULEMANS, A.L., SIPIDO, K.R. & SYS, S.U. (1988). Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ. Res., 62, 358-366.
5. BURNSTOCK, G. (1990). Local mechanisms of blood flow control by perivascular nerves and endothelium. J. Hypertension, 8(Suppl. 7), 95-106.
6. CAMPBELL, D.J. (1987). Circulating and tissue angiotensin systems. J. Clin. Invest., 79, 1-6.
7. CHULAK, C., COUTURE, R. & FOUCART, S. (1995). Modulatory effects of bradykinin on the release of noradrenaline from rat isolated atria. Br. J. Pharmacol., 115, 330-334.
8. COX, S.L., SCHELB, V., TRENDELENBURG, A.U. & STARKE, K. (2000). Facilitation of sympathetic transmitter release by angiotensin and bradykinin requires ongoing Gi-mediated presynaptic inhibition. Naunyn-Schmiedeberg's Arch. Pharmacol., 361(Suppl.), R25.
9. COX, S.L., TRENDELENBURG, A.U. & STARKE, K. (1999). Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br. J. Pharmacol., 127, 1256-1262.
10. DANSER, A.H.J., KONING, M.M., ADMIRAAL, P.J.J., SASSEN, L.M., DERKX, F.H.M., VERDOUW, P.D. & SCHALEKAMP, M.A.D.H. (1992). Production of angiotensin I and II at tissue sites in intact pigs. Am. J. Physiol., 263, H429-H437.
11. DUSTING, G.J., MONCADA, S. & VANE, J.R. (1977). Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins, 13, 3-15.
12. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-376.
13. GONÇALVES, J. & QUEIRÓZ, G. (1996). Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2y-and facilitatory A2A-purinoceptors. Br. J. Pharmacol., 117, 156-160.
14. GUIMARÃES, S., ALBINO-TEIXEIRA, A. & PAIVA, M.Q. (1995). Hypertension and enhanced (-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors. Br. J. Pharmacol., 114, 1595-1598.
15. GUIMARÃES, S., BRANDÃO, F. & PAIVA, M.Q. (1978). A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedeberg's Arch. Pharmacol., 305, 185-188.
16. GUIMARÃES, S., PAIVA, M.Q. & MOURA, D. (1998). Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. Br. J. Pharmacol., 124, 1207-1212.
17. GUIMARÃES, S., PINHEIRO, H., TAVARES, P., LOIO, A. & MOURA, D. (2000). Evidence that pre- and postjunctional angiotensin II receptors are different. Naunyn-Schmiedeberg's Arch. Pharmacol., 361(Suppl.), R81.
18. HENDERSON, A.H., LEWIS, M.J., SHAH, A.M. & SMITH, J.A. (1992). Endothelium, endocardium, and cardiac contraction. Cardiovasc. Res., 26, 305-308.
19. INAGAMI, T. (1999). Molecular biology and signaling of angiotensin receptors: an overview. Am. J. Soc. Nephrol., 10, S2-S7.
20. MAJEWSKI, H. & RAND, M.J. (1981). An interaction between prejunctional α-adrenoceptor and prejunctional β-adrenoceptors. Eur. J. Pharmacol., 69, 493-498.
21. MINSHALL, R.D., YELAMANCHI, V.P., DJOKOVIC, A., MITELICH, D.J., ERDÖS, E.G., RABITO, S.F. & VOGEL, S.M. (1994). Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ. Res., 74, 441-447.
22. MOMBOULI, J.V. & VANHOUTTE, P.M. (1995). Kinins and endothelial control of vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol., 35, 679-705.
23. MÜLLER, D.N., EISCHLI, W., CLOZEL, J.P., HILGERS, K.F., BOHLENDER, J., MÉNARD, J., BUSJAHN, A., GANTEN, D & LUFT, F.C. (1998). Local angiotensin II generation in rat heart. Role of renin uptake. Circ. Res., 82, 13-20.
24. OHLSTEIN, E.H., BROOKS, D.P., FEUERSTEIN, G.Z. & RUFFOLO, R.R. (1997). Inhibition of sympathetic outflow by angiotensin II receptor antagonist eprosartan, but not by losartan, valsartan or irbesartan: relationships to differences in prejunctional angiotensin II receptor blockade. Pharmacology, 55, 244-251.
25. PALMER, R.M.J., FERRIGO, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 325, 524-525.
26. PEACH, M.J. (1977). Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev., 57, 313-370.
27. RUMP, L.C., SCHAIBLE, U., BOHMANN, C., FRANKEN-SCHMIDT, A. & SCHOLLMEYER, P. (1995). Bradykinin facilitates noradrenaline release from human renal cortex in the presence of angiotensin converting enzyme inhibition. Br. J. Pharmacol., 114, 229.
28. SEDAA, K.O., BJUR, R.A., SHINOZUKA, K. & WESTFALL, O.P. (1990). Nerve and drug-induced release of adenine nucleosides and nucleotides from rabbit aorta. J. Pharmacol. Exp. Ther., 252, 1060-1067.
29. SHINOZUKA, K., SEDAA, K.O., BJUR, R.A. & WESTFALL, D.P. (1991). Participation by purines in the modulation of norepinephrine release by methoxamine. Eur. J. Pharmacol., 192, 431-434.
30. SMITH, J.A., SHAH, A.M. & LEWIS, M.J. (1991). Factors released from endocardium of the ferret and pig modulate myocardial contraction. J. Physiol., 439, 1-14.
31. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol., 77, 1-124.
32. TAKEUCHI, K., SHINOZUKA, K., AKIMOTO, H., ISHII, R. & HASHIMOTO, T. (1994). Methoxamine-induced release of endogenous ATP from rabbit pulmonary artery. Eur. J. Pharmacol., 254, 287-290.
33. VAZ-DA-SILVA, M.J., GUIMARÃES, S. & MOURA, D. (1995). Adenosine and the endothelium-dependent modulation of 3H-noradrenaline release in the canine pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 640-645.
34. VAZ-DA-SILVA, M.J., MAGINA, S., DOMINGUES-COUTO, A., MOURA, D. & GUIMARÃES, S. (1996). The role of endothelium in the facilitatory effect of bradykinin on electrically-induced release of noradrenaline in rat cardiac ventricle. Br. J. Pharmacol., 118, 364-368.
35. WORCK, R.H., IBSEN, H., FRANDSEN, E. & DIGEPETERSEN, H. (1997). AT1 receptor blockade and sympathoadrenal response to insulin-induced hypoglycemia in humans. Am. J. Physiol., 272, E414-E421.
36. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMBOE, Y., KOBAYASHI, M., MITSUAI, Y., YSAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature, 32, 411-415.
37. ZIMMERMAN, B.G. & WHITMORE, L. (1967). Effect of angiotensin and phenoxybenzamine on release of norepinephrine in vessels during sympathetic nerve stimulation. Int. J. Neuropharmacol., 6, 27-38.